The biotechnology Accord Agreement is now effective

The biotechnology Accord Agreement is now effective
15, 2012 – The Biotechnology Industry Organization (BIO) and the American Seed Trade Association (ASTA) announced today that the Generic Event Marketability and Access Agreement (GEMAA) is now effective. Following its launch on October 31, five BIO …
Read more on Agri-Pulse

Midday Glance: Biotechnology companies
Midday Glance: Biotechnology companies. NEW YORK — Shares of some top biotechnology companies are mixed at 1 p.m.: Amgen Inc. rose $ .22 or .2 percent, to $ 87.50. Biogen Idec fell $ .38 or .3 percent, to $ 148.73. Celgene Corp. rose $ .03 or percent, …
Read more on CBS News

Pfizer Ventures Invests M In Biotechnology Firm Rhythm
(By Balachander) Biotechnology company Rhythm has expanded its Series B financing to $ 33 million, with an additional $ 8 million coming from the venture capital arm of Pfizer Inc. (NYSE: PFE). This additional financing brings the total capital raised by …
Read more on iStockAnalyst

Leave a Reply